Deb Soholt is the Director of Women's Health at Avera McKennan.
A new study links hormone therapy to heart disease in older women. Since so many women going through menopause find relief of their symptoms with hormone therapy, we wanted to find out what the director of Women's Health at Avera McKennan had to say about this latest study. Action News Anchor Nancy Naeve Brown asked Deb Soholt her thoughts.
Deb Soholt, RN,MS is the Director of Women's Health at Avera McKennan. She says, "You know the interesting thing in hormone therapy and risk for overall health for women. Most of the studies have been on post menopausal women. The women we work with at Avera, Avera Heart Hospital, Avera Women's and Avera Midlife Care for Women, we understand everybody is individual. The reason it's so complicated is that hormones connect with over 400 receptor sites in the body so what is risk for one woman is not necessarily risk for another. I think the interesting thing is women are seeking help with symptoms in a phase we call perimenopause and maybe early postmenopausal. The focus of research has been on older women and they do carry a higher risk when you look at high dosing intervention in hormones. So every woman needs to be looked at individually. Every woman has to look at what cardiac risk factors does she bring to the table and how do we minimalize her personal risk. If you need estrogen, it needs to be balanced with progesterone so that whole complimentary balance exits within a woman's body."
It's all about balance and you should see the experts here at Avera Midlife Care for Women. For more information call 877-AT-AVERA